34 SKIN CARE D5 0.0% -1.0% -1.0%
-2.0% -3.0
-4.0% -5.0% -6.0% -7.0% -8.0%
-1.5% -1.0%
D21 Placebo ■ Blend ■
Placebo Blend 0.1% 6 -7.0%
5.9 5.8 5.7 5.6 5.5 5.4 5.3 5.2 5.1 5
Figure 10: Left: Bar graph shows a significant reduction in the Sensitivity Index score. Right: image modelling of the Sensitivity index according to the application. In vivo study was performed on 37 Caucasian women with all skin types. Daily application on hemiface of 0.1% blend in emulsion versus placebo. Evaluation of skin sensitivity at D0 & D21 with Sym’Index
improvement versus placebo by day 21 (Figure 10).
This type of data is valuable because it moves
the story beyond appearance. It suggests that the blend may be helping to reduce the underlying propensity of skin to react, rather than simply masking a redness endpoint.
Implications for formulators What emerges from this body of evidence is a useful reframing of what soothing should mean in current cutting edge skin care. The category is moving away from isolated ‘anti-redness’ claims toward a more integrated model in which comfort, resilience, and longevity are interdependent. In this model, a successful blend should
ideally modulate irritation-relevant signals, reduce susceptibility to environmental stress, and support the structural biology that underpins healthy epidermal renewal. This broader positioning opens more
commercially useful application space. Beyond classic soothing creams and serums, the same mechanism set can support concepts in anti- redness care, exposome defence, post-shave treatment, barrier-repair maintenance, and reactive-skin well-ageing. Because the science links comfort with resilience, the active gives formulators a language that is both more technical and more future-facing than a simple ‘calming’ claim.
That is why the bisabolol–ginger pairing is
particularly timely. It combines a recognizable soothing heritage with a more advanced scientific rationale: biotechnological sourcing for consistency and sustainability; multi-pathway effects spanning cytokines, COX-2, and oxidative stress; support for COL17A1-linked barrier quality; and visible clinical improvement in both induced irritation and real-world sensitivity metrics
PERSONAL CARE MAGAZINE May 2026 (Figures 1-10).1–4 This breadth gives formulators
flexibility across claims territories while maintaining a technically coherent story from molecule to skin outcome.
Conclusion Sensitive skin can no longer be treated as a superficial inconvenience. It is increasingly clear that discomfort, redness, barrier fragility, and environmental susceptibility are biologically connected. The most credible soothing strategies, therefore, are those that do more than calm a symptom; they help rebalance the conditions that allow sensitivity to persist. Viewed through that lens, SymRelief® green
offers a persuasive model for next-generation soothing. By combining biotechnological bisabolol with organic ginger extract, it aligns sustainability- conscious sourcing with a broad efficacy story that runs from inflammatory signaling to barrier support, exposome protection, and visible clinical benefit. For formulators seeking a more cohesive and technically substantiated sensitive- skin narrative, that is a meaningful step beyond traditional limits.
References 1. Carvalho MC, Gomide LR, Acerbi Júnior FW, Tng D. Potential and future geographical distribution of Eremanthus erythropappus (DC.) MacLeish: a tree threatened by climate change. Floresta e Ambiente. 2019;26(3):e20180455
2. Son YJ, Kwon M, Ro DK, Kim SU. Enantioselective microbial synthesis of the indigenous natural product (−)-α-bisabolol by a sesquiterpene synthase from chamomile (Matricaria recutita). Biochem J. 2014;463(2):239-248
3. Karpuzoglu E, Holladay SD, Gogal RM Jr.
Inflammaging: triggers, molecular mechanisms, immunological consequences, sex differences, and cutaneous manifestations. Front Immunol. 2025;16:1704203
4. Pająk J, Nowicka D, Szepietowski JC. Inflammaging and immunosenescence as part of skin aging — a narrative review. Int J Mol Sci. 2023;24(9):7784
5. Natsuga K, Watanabe M, Nishie W, Shimizu H. Life before and beyond blistering: the role of collagen XVII in epidermal physiology. Exp Dermatol. 2019;28(10):1135-1141
6. Xiang Y, Liu Y, Yang Y, Yan Y, Kim AJ, Guo C, et al. Reduced expression of collagen 17A1 in naturally aged, photoaged, and UV-irradiated human skin in vivo: potential links to epidermal aging. J Cell Commun Signal. 2022;16:421-432
7. Liu Y, Ho C, Wen D, Sun J, Huang L, Gao Y, et al. Targeting the stem cell niche: role of collagen XVII in skin aging and wound repair. Theranostics. 2022;12(15):6446-6454
PCM
8. Franzke CW, Bruckner-Tuderman L, Blobel CP. Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9. J Biol Chem. 2009;284(35):23386-23396
9. Lee CW, Lin ZC, Hu SC, Chiang YC, Hsu LF, Lin YC, et al. Urban particulate matter down- regulates filaggrin via COX2 expression/PGE2 production leading to skin barrier dysfunction. Sci Rep. 2016;6:27995
10. Pilkington SM, Bulfone-Paus S, Griffiths CEM, Watson REB. Inflammaging and the skin. J Invest Dermatol. 2021;141(4 Suppl):1087-1095.
11. Woo YR, Kim HS. Interaction between the microbiota and the skin barrier in aging skin: a comprehensive review. Front Physiol. 2024;15:1322205
12. Quan T. Molecular insights of human skin epidermal and dermal aging. J Dermatol Sci. 2023;112(2):48-53
www.personalcaremagazine.com
Evolution of skin sensitivity
Increase of Sensitivity
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
